Eur Rev Med Pharmacol Sci 2022; 26 (22): 8205-8205
DOI: 10.26355/eurrev_202211_30349

Retraction Note: Vitamin D supplementation during pregnancy inhibits the activation of fetal membrane NF-κB pathway

N. Gurkan

Department of Obstetrics and Gynecology, Medical Park Hospital, Samsun, Turkey


The article “Vitamin D supplementation during pregnancy inhibits the activation of fetal membrane NF-κB pathway, by N. Gurkan, published in Eur Rev Med Pharmacol Sci 2022; 26 (16): 5926-5931–10.26355/eurrev_202208_29532–PMID: 36066168” has been retracted by the author as she stated that Vitamin D was used in the study as supplement and not a drug without the permission of the Ministry. Although Vitamin D is a commonly used supplement during pregnancy, the Local Ethics Committee accepted it as a drug and asked for it to be approved by the Ministry of Health. Therefore, the manuscript has been withdrawn.

This article has been retracted. The Publisher apologizes for any inconvenience this may cause.

Vitamin D supplementation during pregnancy inhibits the activation of fetal membrane NF-κB pathway

Free PDF Download

To cite this article

N. Gurkan
Retraction Note: Vitamin D supplementation during pregnancy inhibits the activation of fetal membrane NF-κB pathway

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 22
Pages: 8205-8205
DOI: 10.26355/eurrev_202211_30349